Jaka jest cena za Asensus Surgical, Inc. (ASXC)

Cena za Asensus Surgical, Inc. (ASXC) wynosi $0.3479

Jaka jest kapitalizacja rynkowa dla Asensus Surgical, Inc. (ASXC)

Kapitalizacja rynkowa dla Asensus Surgical, Inc. (ASXC) wynosi $94.92M

Zyski Asensus Surgical, Inc. (ASXC)

Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.

Rok	Zyski	Zmień
2026 (TTM)	$-83.44M	6.82%
2023	$-78.12M	3.82%
2022	$-75.24M	20.90%
2021	$-62.24M	2.32%
2020	$-60.83M	-61.34%
2019	$-157.33M	141.47%
2018	$-65.15M	-56.01%
2017	$-148.10M	18.00%
2016	$-125.50M	161.62%
2015	$-47.97M	27.41%
2014	$-37.65M	32.77%
2013	$-28.36M	83.84%
2012	$-15.43M	167.89%
2011	$-5.76M	8.58%
2010	$-5.30M	124.13%
2009	$-2.37M	-54.37%
2008	$-5.19M	70.50%
2007	$-3.04M	1,390.69%
2006	$-204.00K	-10.53%
2005	$-228.00K	-48.65%
2004	$-444.00K	-54.04%
2003	$-966.00K	-82.05%
2002	$-5.38M	-997.00%
2001	$600.00K	-77.01%
2000	$2.61M	0.00%

Rok

Zyski

Zmień

2026 (TTM)

$-83.44M

6.82%

2023

$-78.12M

3.82%

2022

$-75.24M

20.90%

2021

$-62.24M

2.32%

2020

$-60.83M

-61.34%

2019

$-157.33M

141.47%

2018

$-65.15M

-56.01%

2017

$-148.10M

18.00%

2016

$-125.50M

161.62%

2015

$-47.97M

27.41%

2014

$-37.65M

32.77%

2013

$-28.36M

83.84%

2012

$-15.43M

167.89%

2011

$-5.76M

8.58%

2010

$-5.30M

124.13%

2009

$-2.37M

-54.37%

2008

$-5.19M

70.50%

2007

$-3.04M

1,390.69%

2006

$-204.00K

-10.53%

2005

$-228.00K

-48.65%

2004

$-444.00K

-54.04%

2003

$-966.00K

-82.05%

2002

$-5.38M

-997.00%

2001

$600.00K

-77.01%

2000

$2.61M

0.00%

Firma	Zyski	Różnica w zyskach	Kraj
Abbott Laboratories ABT.US	$7.51B	-9,101.35%	US
Stryker Corporation SYK.US	$5.15B	-6,269.48%	US
Medtronic plc MDT.US	$5.56B	-6,766.83%	IE
Boston Scientific Corporation BSX.US	$3.86B	-4,727.11%	US
Siemens Healthineers AG SHL.DE	-	-	DE

Firma

Zyski

Różnica w zyskach

Kraj